Healthcare ❯ Public Health ❯ Disease Prevention

Vaccination

COVID-19 Vaccines Flu Vaccine Influenza Vaccination Community Health Flu Vaccination Covid-19 Vaccines COVID-19 Vaccination Surveillance Health Recommendations Covid Vaccines Measles Vaccine Guidelines Booster Shots Hepatitis Vaccines Recommendations Antiviral Treatments Measles COVID-19 Mpox Vaccine Preventive Measures Hepatitis Vaccination Hepatitis B Hib Vaccination Transmission-Blocking Vaccines Preparedness Vaccine Effectiveness Animal Vaccination H3N2 Flu Vaccine Covid Vaccine Chikungunya Vaccine JYNNEOS Vaccine Community Awareness Awareness Immunity Influenza Vaccines DTaP and Tdap Vaccines Tdap Vaccine Immunization Rates Whooping Cough Vaccine Health Messaging Elderly Care Flu Season Cholera Vaccines Norovirus Vaccines Japanese Encephalitis Vaccine Herpes Vaccines Hygiene Practices Influenza Vaccine Health Education At-Risk Populations Measles Vaccination Whooping Cough Vaccination MMR Vaccine Autism Research FSME Vaccination Travel Vaccines Malaria Vaccine Measles Exposure Immunization Rabies Treatment Global Health Initiatives Wildlife Handling

Drifted H3N2 ‘Subclade K’ Spreads to U.S. as Early Flu Wave Builds

Preliminary data indicate reduced vaccine match with continued protection against severe illness.

U.S. Whooping Cough Cases Top 25,000 in 2025 as Kentucky Confirms Third Infant Death

Drifted H3N2 ‘Subclade K’ Drives Early U.S. Flu Uptick Before Holidays

Texas Whooping Cough Cases Quadruple to 3,500 as State Issues Second Straight Health Alert

Salt Lake County Reports Probable First Measles Case After Patient Declines Testing

Chicago Mpox Cases Rise, Prompting Vaccination Push

Cholera Emergency Peaks in Sudan’s Darfur as Treatment Centres Overrun

First Cryo-EM Map of Malaria Fertilization Complex Enables mRNA Vaccine Blocking 99.7% of Transmission

Summer COVID-19 Wave Underway in 25 States Driven by Nimbus Variant

Nimbus COVID Variant Drives 55% of Cases in California

Portable Paper-Based Test Surpasses Standard Methods in Detecting Asymptomatic Malaria

Nimbus Variant Becomes Second-Most Common COVID-19 Strain in U.S.